Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Soligenix, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q1 2023
- Shares held
- 1.44M
- +1.34M (+1,357.0%) vs. Q1 2023
- Total value
- $1.02M
- +$820.1K (+420.1%) vs. Q1 2023
- New holders
- 5
- 2 more added
- Sold out
- 1
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $369.6K |
| Q1 2026 | 15 | $307.4K |
| Q4 2025 | 19 | $600.0K |
| Q3 2025 | 23 | $1.61M |
| Q2 2025 | 15 | $248.2K |
| Q1 2025 | 11 | $313.1K |
| Q4 2024 | 10 | $82.8K |
| Q3 2024 | 7 | $262.4K |
| Q2 2024 | 11 | $259.1K |
| Q1 2024 | 18 | $143.0K |
| Q4 2023 | 20 | $286.5K |
| Q3 2023 | 19 | $500.2K |
| Q2 2023 | 20 | $1.02M |
| Q1 2023 | 16 | $195.2K |
| Q4 2022 | 36 | $1.37M |
| Q3 2022 | 30 | $1.35M |
| Q2 2022 | 28 | $1.91M |
| Q1 2022 | 33 | $2.38M |
| Q4 2021 | 28 | $2.24M |
| Q3 2021 | 34 | $4.35M |
| Q2 2021 | 34 | $4.59M |
| Q1 2021 | 35 | $5.22M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Soligenix, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 5 | $4 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19 | $14 | 0.00% | −1−5.0% | Reduced |
| Wells Fargo & Company | 38 | $27 | 0.00% | +18+90.0% | Added |
| GWM Advisors LLC | 45 | $32 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 87 | $60 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 211 | $149 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 800 | $563 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,257 | $885 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,794 | $1.26K | 0.00% | +1,794 | New |
| Morgan Stanley | 3,994 | $2.81K | 0.00% | +3,100+346.8% | Added |
| Plante Moran Financial Advisors, LLC | 4,778 | $3.36K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,890 | $4.85K | 0.00% | −5,061−42.3% | Reduced |
| Warberg Asset Management LLC | 10,000 | $7.04K | 0.00% | +10,000 | New |
| Virtu Financial LLC | 14,144 | $10.0K | 0.00% | +14,144 | New |
| Geode Capital Management, LLC | 20,922 | $14.5K | 0.00% | −729−3.4% | Reduced |
| First Wilshire Securities Management Inc | 23,334 | $16.0K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 26,765 | $18.8K | 0.00% | −7,179−21.1% | Reduced |
| Anson Funds Management LP | 514,144 | $361.9K | 0.11% | +514,144 | New |
| Sabby Management, LLC | 814,245 | $573.1K | 2.05% | +814,245 | New |
| Hartford Financial Management Inc. | 0 | $0 | 0.00% | −67−100.0% | Sold out |